Previous Close | 9.56 |
Open | 9.69 |
Bid | 9.70 x 0 |
Ask | 9.72 x 0 |
Day's Range | 9.31 - 9.84 |
52 Week Range | 3.84 - 15.50 |
Volume | |
Avg. Volume | 2,275,785 |
Market Cap | 529.578M |
Beta (5Y Monthly) | 2.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -79.20 |
Earnings Date | Jun 12, 2024 - Jun 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.83 |
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for growth.
Canadian cannabis stocks exposed to the U.S. saw a boost in share price this week from rumours that rescheduling of the substance could happen soon. The post What’s Going on With Canadian Pot Stocks? appeared first on The Motley Fool Canada.